Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
15/01/2026 10:33
Jan 15 (Reuters) - Giant Biogene Holding Co Ltd 2367.HK: UNIT RECEIVED MEDICAL DEVICE REGISTRATION CERTIFICATE FROM NMPA CHINA FOR RECOMBINANT COLLAGEN AND SODIUM HYALURONATE SOLUTION Further company coverage: 2367.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan